Conversely, administration of gemcitabine alone could suppress the proportion of Ki-67-positive ICC cells in a xenograft tumour, but could not suppress the stromal α-SMA-positive staining. The gene discussed is MKI67; the disease is intrahepatic cholangiocarcinoma.